Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: Time for reappraisal

Bone Marrow Transplantation

Volumn 46, Issue 9, 2011, Pages 1272-1273

  Fontanet, A ^a   Chalandon, Y ^a   Roosnek, E ^a   Mohty, B ^a   Passweg, J R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FOLINIC ACID;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TOXICITY; DISEASE DURATION; ENGRAFTMENT; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION PREVENTION; NEUTROPENIA; NEUTROPHIL COUNT; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TOXOPLASMOSIS; VIRUS REACTIVATION;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 80052500528     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.285     Document Type: Article

References (10)

1. Copelan E. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Apperley J, Carreras E, Gluckman E. Hematopoietic Stem-Cell Transplantation. The EBMT Handbook, 5th edn. European School of Haematology: Paris, France, 2008.
3. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007 CD005590.
4. De Castro N, Neuville S, Sarfati C, Ribaud P, Derouin F, Gluckman E et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant 2005; 36: 879-883. (Pubitemid 41655614)
5. Fuchs M, Scheid C, Schulz A, Diehl V, Sö hngen D. Trimethoprim/sulfamethoxazole prophylaxis impairs function of mobilised autologous peripheral blood stem cells. Bone Marrow Transplant 2000; 26: 815-816.
6. Lindemulder S, Albano E. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients. Pediatrics 2007; 120: e47-e51. (Pubitemid 47036215)
7. de Jongh CA, Wade JC, Finley RS, Joshi JH, Aisner J, Wiernik PH et al. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung. J Clin Oncol 1983; 1: 302-307. (Pubitemid 14176708)
8. Deeg HJ, Meyers JD, Storb R Graham TC, Weiden PL. Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs. Transplantation 1979; 28: 243-246. (Pubitemid 9251586)
9. Pinching A. Editorial review: Prophylactic and maintenance therapy for opportunist infections in AIDS. AIDS 1988; 2: 335-343. (Pubitemid 19008112)
10. Stolley PD, Schlesselman JJ. Case-Control Studies: Design, Conduct, Analysis. Oxford University Press: Oxford, UK, 1982.